DOCSLIB.ORG

Escherichia Coli and Shigella Species M

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Apr. 1988, p. 201-206 Vol. 38. No. 2 0020-7713/88/040201-06$02.OO/O Specificity of a Monoclonal Antibody for Alkaline Phosphatase in Escherichia coli and Shigella Species M. 0. HUSSON,1*2*P. A. TRINELY2C. MIELCAREK,2 F. GAVINI,2 C. CARON,lq2D. IZARD,l AND H. LECLERC' Faculte' de Me'decine, Laboratoire de Bacte'riologie A, 59045 Lille Cedex, France' and Unite' Institut National de la Sante' et de la Recherche Me'dicale 146, Domaine dir CERTIA, 59650 Villeneuve-d'Ascq Cedex, France2 The specificity of monoclonal antibody 2E5 for the alkaline phosphatase of Escherichia coli was studied against the alkaline phosphatases of 251 other bacterial strains. The organisms used included members of the six species of the genus Escherichia (E. coli, E. fergusonii, E. hermannii, E. blattae, E. vulneris, E. adecarboxylata), 41 species representing the family Enterobacteriaceae, and, in addition, Pseudomonas aeruginosa, Aeromonas spp., Plesiomonas shigelloides, Acinetobacter calcoaceticus, and Vibrio cholerae non-01. Three methods were used. An enzyme-linked immunosorbent assay was performed against 21U of alkaline phosphatase per ml; immunofluorescence against bacterial cells and Western blotting against periplasmic proteins were also used. All of our experiments demonstrated the high specificity of monoclonal antibody 2E5. This antibody recognized only E. coli (118 strains tested) and the four species of the genus Shigella (S. sonnei, S. flexneri, S. boydii, S. dysenteriae; 12 strains tested). Since the description of hybridoma production by Kohler mouse immunized with purified Escherichia coli ATCC and Milstein in 1975 (14), many monoclonal antibodies 10536 alkaline phosphatase as described elsewhere (12). (MoAbs) have been produced against microorganisms. Some Specificity testing of MoAb 2E5. (i) ELISA. Activated of these are now used for the detection of bacteria, such as polyvinyl chloride microtitration plates (Nunc or Flow Lab- Chlamydia trachomatis (29), Legionella pneumophila (9), oratories) were coated with 100 pl of alkaline phosphatase (2 and group B Streptococcus (19). The success of such anti- IU/ml) in phosphate-buffered saline (PBS; 0.05 M, pH 9.6) bodies is correlated with their high antigenic affinity and by incubating the preparation at 4°C for 18 h. The plates especially with their specificity, as established by enzyme- were washed three times with 200 pl of this buffer and were linked immunosorbent assay (ELISA), immunofluores- saturated by using 2% bovine serum albumin in PBS in the cence, or immunoblotting against a great number of various wells at 37°C for 1 h. After three washes with 200 pl of PBS bacterial species. containing 0.05% Tween 20, the plates were covered and Escherichia coli alkaline phosphatase was chosen to im- stored at 4°C. The immune reaction was performed by munize BALB/c mice and to obtain specific antibodies. This adding 100 pl of MoAb 2E5 for 1 h at 37°C. Subsequently, enzyme protein is a dimer composed of two identical sub- the wells were washed three times with PBS containing units. It is localized in the periplasmic space and at the cell 0.05% Tween 20 and then incubated with 100 r~.lof horse- surface of the gram-negative cell envelope in association radish peroxidase-conjugated goat anti-mouse immunoglob- with lipopolysaccharides (8, 17). Studies of its immunologi- ulin (Institut Pasteur Production Laboratories), Peroxidase cal properties by immunoprecipitation or quantitative micro- activity was detected colorimetrically by adding 0.04% 0- complement fixation (6, 8) have demonstrated a protein phenylenediamine in citrate-phosphate buffer (pH 5) supple- sequence divergence between Escherichia coli and some mented with 0.006% hydrogen peroxide. The reaction was other species of Enterobacteriaceae. Recently, we produced developed in the dark for 15 min at room temperature and MoAbs against alkaline phosphatase of Escherichia coli (12). stopped by adding 30 pl of 1.3 M H2S0,. Absorbance at 490 In this paper, we describe the specificity of MoAb 2E5, nm was measured with a micro-ELISA plate photometer which was studied by using the three techniques described (Autoreader MR600; Dynatech Laboratories, Inc.). Assays above. were carried out in duplicate. Negative controls (serum of nonimmunized BALB/c mice) and positive controls (serum MATERIALS AND METHODS of immunized BALB/c mice) were included in each test. Reactions were considered positive when the mean of repli- Bacterial strains and alkaline phosphatase extraction. The cate titrations was two times higher than the mean of 251 bacterial strains included in this study are listed in Table negative controls. For some species (Escherichia hermannii, 1. Cells were grown at 30°C for 18 h in phosphate limiting Escherichia vulneris, Enterobacter cloacae, Proteus vul- medium to derepress alkaline phosphatase synthesis, as garis, Proteus penneri, Providencia rustigianii, Pvovidencia described by Garen and Levinthal (11). Bacteria were har- alcalifaciens, Yersinia pseudutuberculosis, Buttiauxella vested, and alkaline phosphatase was released with other agrestis) no enzymatic activity was found after heat treat- periplasmic proteins by heat treatment at 56°C in tris(hy- ment or sonication. In these cases, the ELISA was per- droxymethy1)aminomethane (Tris) hydrochloride buffer (pH formed by using periplasmic proteins (15 pg/ml). 8) as described by Tsuchido et al. (26). Alkaline phosphatase (ii) Immunofluorescence assay. Indirect immunofluores- activity was assayed with 0.2 mg of the substrate p-nitro- cence was performed with MoAb 2E5 and fluorescein iso- phenyl phosphate per ml in 1 M Tris buffer (pH 8) at 400 nm. thiocyanate-conjugated rabbit anti-mouse immunoglobulin MoAb 2E5 production. MoAb 2E5 was obtained from the (Institut Pasteur Production). The working dilutions of the fusion of SP20/Ag-14 myeloma cells and spleen cells from a MoAbs and the conjugate were determined by checkerboard titration. PBS (pH 7.6) was used to dilute the antibody and * Corresponding author. the conjugate. The MoAb and the conjugate were diluted 201 :!02 HUSSON ET AL. INT. J. SYST.BACTERIOL. TABLE 1. Strains tested and cross-reactivities of MoAb 2E5 specific for Escherichia coli alkaline phosphatase Cross-reactivity as determined by: Bacterial strain(s)" ELISA against Immuno- enzymatic fluorescence of Western extract bacterial cells Escherichia spp. strains E. coli ATCC 10536 + + E. coli (38 environmental strains) + E. coli (59 medical strains) + E. coli (20 fecal strains) + E. fergusonii CDC 3296-73, CDC 3014-74 - E. fergusonii CDC 3458-74, CDC 1016-74, CDC 568-73 - E. hermannii ATCC 33650, CDC 899-73 E. hermannii CDC 2808-70, CDC 1933-74, CDC 2472-72 E. vulneris ATCC 33821, CDC 2898-73, CDC 3763-72, CDC 2954-71 E. blattae ATCC 29907 E. adecarboxylata ATCC 23216 Shigella spp. strains S. sonnei ATCC 9290, CUETM 77-73 + S. sonnei CFML 969 S. dysenteriae WRAIR 1617, CUETM 79-327 S.flexneri WRAIR 24570, CFML 970, ATCC 12661, CFML 17 S. boydii CDC 2406-51, WRAIR C10, CFML 398 Salmonella spp. strains S. typhimurium ATCC 23565 S. typhimurium ATCC 7823, CFML 1010 S. paratyphi CUETM 79-368 S. derby CFML 303, CFML 302 S. sohio CFML 305, CFML 317 S. enteritidis CFML 308 S. arizonae ATCC 7823 Levinea spp. strains L. rnalonatica CDC 25408 L. malonatica CUETM 77-12, CFML 359, CFML 416, CFML 875 L. amalonatica CDC 25406, CUETM 77-9 ICitrobacter freundii ATCC 8090 ICitrobacterfreundii CDC 460-61, CUETM 78-263, CUETM 78-280, CUETM 78-273, CFML 615, CFML 495, CFML 624 (Citrobacrerfreundii CU ETM 77-166, CUETM 77-152 Klebsiella spp. strains K. pneumoniae ATCC 13882 K. pneumoniae CUETM 77-130, CUETM 77-174, CUETM 78-146, CUETM 78-258, CUETM 77-180, CFML 509, CFML 220 K. oxytoca ATCC 13182, ATCC 77-146, CUETM 78-177, CUETM 78-182, CUETM 78-181, CUETM 78-178, CFML 685, CFML 173, CFML 48 Enterobacter spp. strains E. cloacae ATCC 13047 E. cloacae CUETM 77-121, CUETM 77-120, CUETM 77-126, CUETM 77-116, CUETM 77-125 E. amnigenus ATCC 33072 E. aerogenes ATCC 13048, CUETM 67-71 E. gergoviae ATCC 33028 E. sakazakii ATCC 29544 E. taylorae CDC 697-81 E. agglomerans ATCC 27155 Hafnia alvei CFML 877, CFML 880, CFML 884, CFML 883, CFML 165 Serratia spp. strains S. marcescens ATCC 16880 S. marcescens CUETM 78-210, CUETM 78-212, CUETM 78-248, CUETM 78-164, CFML 485, CFML 757 S. liquefaciens CUETM 78-243, CUETM 78-172, CUETM 78-244 S. liquefaciens CUETM 78-174, CUETM 78-228 S. fonticola ATCC 29844, CUETM 78-10 S. odorifera CUETM 83-88 Proteus spp. strains P. rnirabilis ATCC 29906 P. mirabilis CFML 699, CFML 1004 P. vulgaris ATCC 13315 P. penneri ATCC 33519 Continued on following page VOL. 38, 1988 SPECIFICITY OF MoAb 203 TABLE 1-Continued Cross-reactivity as determined by: Bacterial straints)" ELISA against Immuno- enzymatic fluorescence of extract bacterial cells blotting Morganella morganii ATCC 25830 Providencia spp. strains P. rustigianii ATCC 33673 P. stuartii ATCC 29914 P. alcalfaciens ATCC 9886 Yersinia spp. strains Y. enterocolitica CDC 135 Y. pseudotuberculosis ATCC 29833 Rahnella aquatilis ATCC 33071 Ewingella americana ATCC 33852 Buttiauxella agrestis ATCC 33320 Kluyvera spp. strains K. ascorbata ATCC 33434 K. cryocrescens ATCC 33435 Edwarsiella tarda CUETM 78-301 Cedecea spp. strains C. lapagei ATCC 33432 C. davisae ATCC 33431 Leminorella spp. strains L. richardii ATCC 33998 L. grimondii ATCC 33999 Pseudomonas aeruginosa ATCC 10145 Aeromonas spp. strains A. sobria CDC 9538-76 A. punctata ATCC 15468 A. hydrophila ATCC 7966 Acinetobacter lwofi ATCC 17986 Plesiomonas shigelloides ATCC 14029 Vibrio cholerae non-01 CUETM 77-100 ATCC, American Type Culture Collection, Rockville. Md.; CDC, Centers for Disease Control, Atlanta, Ga.; WRAIR, Walter Reed Army Institute of Research, Washington, D.C.; CUETM, Collection de I'unite Ecotoxicologie Microbienne, Villeneuve d' Ascq, France; CFML, Collection Faculte de Mkdecine de Lille, Lille, France. +, Positive; -, negative; (-), no alkaline phosphatase activity found, ELISA performed against periplasmic proteins extracted by heat treatment (26).
Recommended publications
  • Escherichia Vulneris As a Cause of Bacteremia in a Patient with Chronic

    Escherichia Vulneris As a Cause of Bacteremia in a Patient with Chronic

    110 Correspondence 3. Auerbach O. Acute generalized miliary tuberculosis. Am J Pathol 12. Takhtani D, Gupta S, Suman K, Kakkar N, Challa S, Wig JD, et al. 1944;20:121—36. Radiology of pancreatic tuberculosis: a report of three cases. Am 4. Bhansali SK. Abdominal tuberculosis. Experience with 300 cases. J Gastroenterol 1996;91:1832—4. Am J Gastroenterol 1977;67:324—37. 13. Chen CH, Yang CC, Yeh YH, Yang JC, Chou DA. Pancreatic 5. Franco-Paredes C, Leonard M, Jurado R, Blumberg HM, Smith RM. tuberculosis with obstructive jaundice–—a case report. Am J Tuberculosis of the pancreas: report of two cases and review of Gastroenterol 1999;94:2534—6. the literature. Am J Med Sci 2002;323:54—8. 14. Varshney S, Johnson CD. Tuberculosis of the pancreas. Postgrad 6. Pombo F, Diaz Candamio MJ, Rodriguez E, Pombo S. Pancreatic Med J 1995;71:564—6. tuberculosis: CT findings. Abdom Imaging 1998;23:394—7. 7. Demir K, Kaymakoglu S, Besisik F, Durakoglu Z, Ozdil S, Kaplan Y, Ariel S. Eyal* et al. Solitary pancreatic tuberculosis in immunocompetent V.O.L. Karusseit patients mimicking pancreatic carcinoma. J Gastroenterol Hepa- Department of Surgery, University of Pretoria, tol 2001;16:1071—4. Pretoria, South Africa 8. Liu Q, He Z, Bie P.Solitary pancreatic tuberculous abscess mimick- ing pancreatic cystadenocarcinoma: a case report. BMC Gastro- *Corresponding author. Tel.: +27 82 375 4155 enterol 2003;3:1—6. E-mail address: [email protected] 9. Rezeig MA, Fashir BM, Al-Suhaibani H, Al-Fadda M, Amin T, Eisa H.
  • Distribution of Bacterial 1,3-Galactosyltransferase Genes In

    Distribution of Bacterial 1,3-Galactosyltransferase Genes In

    Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome Emmanuel Montassier, Gabriel Al-Ghalith, Camille Mathé, Quentin Le Bastard, Venceslas Douillard, Abel Garnier, Rémi Guimon, Bastien Raimondeau, Yann Touchefeu, Emilie Duchalais, et al. To cite this version: Emmanuel Montassier, Gabriel Al-Ghalith, Camille Mathé, Quentin Le Bastard, Venceslas Douillard, et al.. Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome. Frontiers in Immunology, Frontiers, 2020, 10, pp.3000. 10.3389/fimmu.2019.03000. inserm-02490517 HAL Id: inserm-02490517 https://www.hal.inserm.fr/inserm-02490517 Submitted on 25 Feb 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. ORIGINAL RESEARCH published: 13 January 2020 doi: 10.3389/fimmu.2019.03000 Distribution of Bacterial α1,3-Galactosyltransferase Genes in the Human Gut Microbiome Emmanuel Montassier 1,2,3, Gabriel A. Al-Ghalith 4, Camille Mathé 5,6, Quentin Le Bastard 1,3, Venceslas Douillard 5,6,7, Abel Garnier 5,6,7, Rémi Guimon 5,6,7, Bastien Raimondeau 5,6, Yann Touchefeu 8,9, Emilie Duchalais 8,9, Nicolas Vince 5,6, Sophie Limou 5,6, Pierre-Antoine Gourraud 5,6,7, David A.
  • Escherichia Fergusonii: a New Emerging Bacterial Disease of Farmed Nile Tilapia (Oreochromis Niloticus)

    Escherichia Fergusonii: a New Emerging Bacterial Disease of Farmed Nile Tilapia (Oreochromis Niloticus)

    Global Veterinaria 14 (2): 268-273, 2015 ISSN 1992-6197 © IDOSI Publications, 2015 DOI: 10.5829/idosi.gv.2015.14.02.9379 Escherichia fergusonii: A New Emerging Bacterial Disease of Farmed Nile Tilapia (Oreochromis niloticus) A.Y. Gaafar, A.M. Younes, A.M. Kenawy, W.S. Soliman and Laila A. Mohamed Department of Hydrobiology, National Research Centre (NRC), El-Bohooth Street (Formerly El-Tahrir St.) Dokki, Gizza 12622, Egypt Abstract: Tilapia is one of the most important cultured freshwater fish in Egypt. In June (2013) an unidentified bacterial disease outbreak occurred in earthen ponds raised Nile tilapia (Oreochromis niloticus). The API 20E test identified the strain as sorbitol-negative and positive for ADH, ornithine decarboxylase and amygdalin and provided the code 5144113, corresponding to E. fergusonii. The clinical signs of diseased fish showed emaciation, focal reddening of the skin at the base of the fins, exophthalmia with inflammation of periorbital area. Postmortem lesions showed enlargement of gallbladder and spleen with discolored hepatopancreas and congested posterior kidney. Lethal Dose fifty (LD50 ) was performed for experimental infection studies. Histopathological examination of naturally as well as experimentally infected specimens revealed pathological lesions in the hepatopancreas, posterior kidney, spleen, myocardium, skin and gills. The lesions ranged from circulatory, degenerative changes and mononuclear cells infiltrations to necrotic changes in the corresponding organs. As a conclusion, this study was the first evidence that E. fergusonii can infect fish especially farmed tilapia, causing considerable mortality and morbidity, in heavily manured earthen ponds. E. fergusonii causes significant pathological lesions in tilapia that are comparable to other susceptible terrestrial animals.
  • Symposium Abstracts

    Symposium Abstracts

    Symposium Abstracts S1 Microbiological Environmental Testing and Validation: Leading-edge Issues for Low-moisture Foods JEAN-LOUIS CORDIER, Nestlé Nutrition, Operations/Quality Management, Vevey, Switzerland DONALD L. ZINK, Food and Drug Administration, Center for Food Safety and Applied Nutrition, College Park, MD, USA STEVEN J. GOODFELLOW, Deibel Laboratories, Inc., Gainesville, FL, USA MARK A. MOORMAN, Kellogg Company, Battle Creek, MI, USA ROBERT L. BUCHANAN, University of Maryland, Center for Food Safety and Security Systems, College Park, MD, USA Recent outbreaks of foodborne illness in several low-moisture foods (i.e., peanuts, peanut butter, cookie dough, etc.) have brought a growing public awareness of the complexities involved with the processing of this category of foods where traditional sanitation practices Symposium may not be applied or practical. As a result, the food industry and FDA have rallied to bring together best available thinking and practices necessary to assure control over foodborne hazards in such processes. However, one leading edge area that still remains a subject that offers opportunities for improvement is how control measures are verified in these processing environments through microbiological testing.This symposium will “zero in” on the challenges that face both food processors and food regulators in the area of environmental monitoring for these low moisture continuous processes. S2 Data Deluge, Interacting Players and Complex Networks in Food Sciences – Computational Tools to Tackle Food- related Complexities RéKA ALBERT, Pennsylvania State University, University Park, PA, USA MARK TAMPLIN, Food Safety Centre, Hobart, TAS, Australia GARY BARKER, Institute of Food Research, Norwich, United Kingdom JÓZSEF BARANYI, Institute of Food Research, Norwich, United Kingdom Food Science is one of the most multi-disciplinary sciences, consequently a holistic approach is not only desirable but rather a necessity, in order to integrate various food-related complex systems.
  • Escherichia Hermannii Infections in Humans: a Systematic Review

    Escherichia Hermannii Infections in Humans: a Systematic Review

    Tropical Medicine and Infectious Disease Review Escherichia hermannii Infections in Humans: A Systematic Review Petros Ioannou Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Crete PC 71500, Greece; [email protected]; Tel.: +30-2810-392728, Fax: +30-2810-392359 Received: 7 January 2019; Accepted: 18 January 2019; Published: 21 January 2019 Abstract: Eshcerichia hermannii is a member of the Enterobacteriaceae, first described in 1982 and reclassified as a distinct species in the Escherichia genus after identifying biochemical and genomic differences from E. coli. It is a rare cause of human infections and is supposed to be a co-infector rather than an autonomous cause of infection. The aim of this systematic review was to record and evaluate all available evidence regarding human infections by E. hermannii. A systematic review of PubMed (through 21 December 2018) for studies providing epidemiological, clinical, and microbiological information, as well as treatment data and outcomes of E. hermannii infections was performed. A total of 16 studies, containing data of 17 patients, were eventually included in the analysis. The most common E. hermannii infections were bacteremias, urinary tract, and central nervous system infections. The complication rate, like the occurrence of sepsis, was high. Cephalosporins and aminoglycosides were the most common agents used for treatment. This systematic review describes bacterial infections by E. hermannii and provides information on the epidemiology, clinical presentation, antibiotic resistance, treatment, and outcomes associated with these infections. Keywords: Escherichia hermannii; bacteremia; UTI; urinary tract infection 1. Introduction Escherichia hermannii is a gram-negative bacterium that belongs in the family of Enterobacteriaceae and was first described in 1982 [1].
  • Escherichia Coli Patógeno Extra Intestinal (Expec): Atributos De Virulencia, Epidemiología Molecular Y Resistencia a Antibióticos

    Escherichia Coli Patógeno Extra Intestinal (Expec): Atributos De Virulencia, Epidemiología Molecular Y Resistencia a Antibióticos

    Escherichia coli patógeno extra intestinal (ExPEC): Atributos de virulencia, Epidemiología Molecular y Resistencia a Antibióticos Tesis de Doctorado PEDECIBA Área Biología, Sub-área Microbiología Rafael Vignoli Orientador: Dr. Alejandro Chabalgoity Co-orientador: Dr. Gabriel Gutkind Departamento de Bacteriología y Virología Instituto de Higiene-Facultad de Medicina Montevideo-Uruguay Abreviaturas: ABC ATP binding cassette AMM Alta Más a Molecular AUC ROC Area bajo la Curva ROC BLEA β-lactamasa de Espectro Ampliado BLEE β-lactamasa de Espectro Extendido BMM Baja Más a Molecular CEACAMs Moléculas de antígeno carcinoembrionario relacionado a adhesión celular CIM Concentrción Inhibitoria Mínima CLSI Clinical and Laboratory Standards Institute CNF-1 Factor necrosante de toxicidad tipo 1 DAF Decay Accelerating Factor Dam deoxi-adenosin metiltransferasa EUCAST European Committee on Antimicrobial Susceptibility Testing ExPEC E. coli patógenas extra intestinales GCA Grupo Clonal A GF Grupos Filogenéticos GRTFQ Genes de Resistencia Transferibles a Fluoro Quinolonas GTPasa guanosina trifosfatasa IS Secuencia de Inserción ITU Infección del Tracto Urinario MATE Multidrug And Toxic-compound Extrusion MFS Major Facilitator Superfamily MLST Multi Locus Sequence Typing (Tipificación de Secuencias Multi Locus) MPS Muerte Post Segregasional MR Manosa Resistente MRD Multi Resistentes a Drogas MS Manosa Sensible NAcGlc N-acetil glucosamina NAcMur N-acetilmurámico NADPH Nicotinamida Adenin di nucleótido fosfato forma reducida PBP Penicillin Binding Proteins
  • Performance Characterization of the IRIDICA™ BAC SFT Assay* for Detection and Identification of Diverse Bacteria and Candida in Tissues and Body fluids

    Performance Characterization of the IRIDICA™ BAC SFT Assay* for Detection and Identification of Diverse Bacteria and Candida in Tissues and Body fluids

    Performance characterization of the IRIDICA™ BAC SFT Assay* for detection and identification of diverse bacteria and Candida in tissues and body fluids Mark W. Frinder, David Metzgar, Megan Rounds, Heather E. Carolan, Donna M. Toleno, Rangarajan Sampath, David J. Ecker, Lawrence B. Blyn Ibis Biosciences, an Abbott Company, Carlsbad, CA, USA Color Key Table 2: Potentially interfering substances tested with the 4 core organisms at 3X Objectives: Identifying causal organisms in Results: The BAC SFT Assay was able to detect and identify all IRIDICA detections, matched LOD in synovial Fluid, muscle tissue, and diluent matrices.Data shown reflects IRIDICA detections, unmatched Standard of care detections, missed by IRIDICA tissue and body fluid infections through tested organisms at concentrations of 5 to 1000 CFU/sample, concentration in the final 5ml sample. No interference was observed (all 4 targets and their associated antibiotic resistance markers were successfully culture-based methods is time-consuming and the sensitivity of the assay was comparable between Burkholderia vietnamiensis (1) and challenging. Culture-based methods are tissue, body fluid, and sample diluent matrices (Figure 1). The detected in 3/3 samples). Micrococcus luteus (1) Corynebacterium striatum (1) often rendered ineffective by antibiotic assay was able to detect organisms in the presence of diverse Test Substance Concentration Test Substance Concentration Corynebacterium accolens (2) Propionibacterium acnes (5) Pseudomonas entomophila/putida (1) pre-treatment, the presence of fastidious or tissues or fluids (Table 1), and potentially interfering Bilirubin 171 µmol/L * Doxycycline 67.5 µmol/L Acinetobacter junii (4) Hemoglobin 2 g/L Fluconazole 245 µmol/L uncultureable species, and growth inhibition substances (Table 2).
  • One City; the Extent of Shiga- Toxin Producing Escherichia Coli in Cape Town

    One City; the Extent of Shiga- Toxin Producing Escherichia Coli in Cape Town

    One Health -One City; the extent of Shiga- toxin producing Escherichia coli in Cape Town. By University of Cape Town John Bosco Kalule Submitted to the University of Cape Town for the degree of Doctor of Philosophy in Medical Microbiology June 2017 The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgement of the source. The thesis is to be used for private study or non- commercial research purposes only. Published by the University of Cape Town (UCT) in terms of the non-exclusive license granted to UCT by the author. University of Cape Town Declaration I, John Bosco Kalule, hereby declare that the work on which this thesis is based is my original work and that neither the whole work nor any part of it has been, is being, or is to be submitted for another degree in this or any other university. Signature: signature removed Date: 7th 08 2017 Supervisor: Professor Mark Patrick Nicol (MBBCh, M.Med (Med Microbiol), SA FCPath (Microbiol),PhD)1, 2, 3 1Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. 2Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa. 3National Health Laboratory Service of South Africa, Groote Schuur Hospital, Cape Town, South Africa Co-supervisors: Dr Karen. H. Keddy (BSc (Med), MBBCh, MMed (Microbiol), FCPath SA (Microbiol), DTM&H, PhD)4, 5 4Centre for Enteric Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/Ijsem.0.001485

    International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/Ijsem.0.001485

    International Journal of Systematic and Evolutionary Microbiology (2016), 66, 5575–5599 DOI 10.1099/ijsem.0.001485 Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov. Mobolaji Adeolu,† Seema Alnajar,† Sohail Naushad and Radhey S. Gupta Correspondence Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Radhey S. Gupta L8N 3Z5, Canada [email protected] Understanding of the phylogeny and interrelationships of the genera within the order ‘Enterobacteriales’ has proven difficult using the 16S rRNA gene and other single-gene or limited multi-gene approaches. In this work, we have completed comprehensive comparative genomic analyses of the members of the order ‘Enterobacteriales’ which includes phylogenetic reconstructions based on 1548 core proteins, 53 ribosomal proteins and four multilocus sequence analysis proteins, as well as examining the overall genome similarity amongst the members of this order. The results of these analyses all support the existence of seven distinct monophyletic groups of genera within the order ‘Enterobacteriales’. In parallel, our analyses of protein sequences from the ‘Enterobacteriales’ genomes have identified numerous molecular characteristics in the forms of conserved signature insertions/deletions, which are specifically shared by the members of the identified clades and independently support their monophyly and distinctness. Many of these groupings, either in part or in whole, have been recognized in previous evolutionary studies, but have not been consistently resolved as monophyletic entities in 16S rRNA gene trees. The work presented here represents the first comprehensive, genome- scale taxonomic analysis of the entirety of the order ‘Enterobacteriales’.
  • Higher Prevalence of Extended-Spectrum Cephalosporin

    Higher Prevalence of Extended-Spectrum Cephalosporin

    antibiotics Article Higher Prevalence of Extended-Spectrum Cephalosporin-Resistant Enterobacterales in Dogs Attended for Enteric Viruses in Brazil Before and After Treatment with Cephalosporins Marília Salgado-Caxito 1,2,* , Andrea I. Moreno-Switt 2,3, Antonio Carlos Paes 1, Carlos Shiva 4 , Jose M. Munita 2,5 , Lina Rivas 2,5 and Julio A. Benavides 2,6,7,* 1 Department of Animal Production and Preventive Veterinary Medicine, School of Veterinary Medicine and Animal Science, Sao Paulo State University, Botucatu 18618000, Brazil; [email protected] 2 Millennium Initiative for Collaborative Research on Bacterial Resistance (MICROB-R), Santiago 7550000, Chile; [email protected] (A.I.M.-S.); [email protected] (J.M.M.); [email protected] (L.R.) 3 Escuela de Medicina Veterinaria, Pontificia Universidad Católica de Chile, Santiago 8940000, Chile 4 Faculty of Veterinary Medicine and Zootechnics, Universidad Cayetano Heredia of Peru, Lima 15102, Peru; [email protected] 5 Genomics and Resistant Microbes Group, Facultad de Medicina Clinica Alemana, Universidad del Desarrollo, Santiago 7550000, Chile 6 Departamento de Ecología y Biodiversidad, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8320000, Chile 7 Centro de Investigación para la Sustentabilidad, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8320000, Chile Citation: Salgado-Caxito, M.l.; * Correspondence: [email protected] (M.S.-C.); [email protected] (J.A.B.) Moreno-Switt, A.I; Paes, A.C.; Shiva, C.; Munita, J.M; Rivas, L.; Abstract: The extensive use of antibiotics is a leading cause for the emergence and spread of antimicro- Benavides, J.A Higher Prevalence of Extended-Spectrum Cephalosporin- bial resistance (AMR) among dogs.
  • Studies on the Prevalence of Enterobacteriaceae in Chickens and Chicken Eggs

    Studies on the Prevalence of Enterobacteriaceae in Chickens and Chicken Eggs

    BS. VET . MED . J. 7TH SCI . CONF . VOL . 22, NO.1, P.136-144 Beni-Suef Veterinary Medical Journal Studies on the Prevalence of Enterobacteriaceae in Chickens and Chicken eggs 1 2 3 4 M. M. Amer ; A. H. M. Dahshan ; Hala S. Hassan and Asmaa A. Mohamed 1 Department of Poultry Diseases, Faculty of Veterinary Medicine, Cairo University, 2 Department of Poultry Diseases, Faculty of Veterinary Medicine, Beni-Suef University, 3 Department of Bacteriology and Mycology, Faculty of Veterinary Medicine, Beni-Suef University and 4 Veterinary Supervisor, Animal Production, Faculty of Agriculture, Al-Minia University This study was done to investigate the prevalence of the Enterobacteriaceae in chickens and eggs. Isolation of forty four different bacterial isolates belonging to Enterobacteriaceae from chicken egg samples, cloacal swabs and swabs from Hatcheries’s floor, the isolates from commercial flock swabs were biochemically identified as E coli, P. mirabilis E Sakazakii and E .cloacae by incidence 22%, 55 %, 11% and 11 % respectively. The isolates from Layers and broilers breeder cloacal swabs were biochemically identified to be E. coli, P. mirabilis E. fergusonii and E .cloacae by incidence 20 %, 20 %, 20% and 40 % respectively. The isolates from commercial eggs were biochemically identified to be Pantoea Sp. , Kluyvera sp., E Sakazakii , E.aerogenes and E.harmanii by incidence 33.3% , 16.6% , 16.6% , 16.6% and 16.6 % respectively. The isolates from fertilized egg samples were biochemically identified as E Sakazakii , E. fergusonii , E.coli , E. Cloacae , Aeromonas ,S. Anatum and Prov. Alcolifaciens with a number of 1 ,1, 3, 3, 2, 2 and 1 , incidence 8% , 8% , 23% , 23% , 15% , 15% and 8 % respectively.
  • Intrahepatic Bacterial Metataxonomic Signature in Non-Alcoholic Fatty Liver

    Intrahepatic Bacterial Metataxonomic Signature in Non-Alcoholic Fatty Liver

    Hepatology ORIGINAL RESEARCH Intrahepatic bacterial metataxonomic signature in Gut: first published as 10.1136/gutjnl-2019-318811 on 2 January 2020. Downloaded from non- alcoholic fatty liver disease Silvia Sookoian ,1,2 Adrian Salatino,1,3 Gustavo Osvaldo Castaño,4 Maria Silvia Landa,1,3 Cinthia Fijalkowky,1,3 Martin Garaycoechea,5 Carlos Jose Pirola 1,3 ► Additional material is ABSTRact published online only. To view Objective We aimed to characterise the liver tissue Significance of this study please visit the journal online bacterial metataxonomic signature in two independent (http:// dx. doi. org/ 10. 1136/ What is already known on this subject? gutjnl- 2019- 318811). cohorts of patients with biopsy- proven non- alcoholic fatty liver disease (NAFLD) diagnosis, as differences in ► The natural history of non- alcoholic fatty liver For numbered affiliations see disease (NAFLD) is modulated by genetic and end of article. the host phenotypic features—from moderate to severe obesity—may be associated with significant changes in environmental factors. ► Recent discoveries revealed the role of the Correspondence to the microbial DNA profile. Dr Silvia Sookoian, Institute Design and methods Liver tissue samples from 116 gut microbiota in human health and disease, of Medical Research A Lanari, individuals, comprising of 47 NAFLD overweight or including NAFLD. However, the impact of the University of Buenos Aires moderately obese patients, 50 NAFLD morbidly obese liver tissue microbial DNA profiling on the Faculty of Medicine, Buenos disease biology remains unknown. Aires, 10109 CABA, Argentina; patients elected for bariatric surgery and 19 controls, ssookoian@ intramed. net were analysed using high- throughput 16S rRNA gene What are the new findings? Dr Carlos Jose Pirola; sequencing.